[HTML][HTML] Prognostic factors for myositis-associated interstitial lung disease

T Fujisawa, H Hozumi, M Kono, N Enomoto… - PLoS one, 2014 - journals.plos.org
Background Interstitial lung disease (ILD) is a common manifestation of polymyositis (PM),
dermatomyositis (DM), and clinically amyopathic dermatomyositis (CADM); however, little is …

Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study

H Hozumi, Y Nakamura, T Johkoh, H Sumikawa… - BMJ open, 2013 - bmjopen.bmj.com
Objectives To investigate the risk factors and prognosis associated with acute exacerbation
(AE) in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD) …

Chemoselective asymmetric intramolecular dearomatization of phenols with α-diazoacetamides catalyzed by silver phosphate

H Nakayama, S Harada, M Kono… - Journal of the American …, 2017 - ACS Publications
We report asymmetric dearomatization of phenols using Ag carbenoids from α-
diazoacetamides. The Ag catalyst promoted intramolecular dearomatization of phenols …

[HTML][HTML] Rheumatoid lung disease: prognostic analysis of 54 biopsy-proven cases

Y Nakamura, T Suda, Y Kaida, M Kono, H Hozumi… - Respiratory …, 2012 - Elsevier
OBJECTIVE: To investigate the prognostic significance of histopathological characteristics in
patients with biopsy-proven rheumatoid lung disease (RLD). MATERIALS AND METHODS …

[HTML][HTML] Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective …

H Hozumi, N Enomoto, M Kono, T Fujisawa, N Inui… - PLoS …, 2015 - journals.plos.org
Background In polymyositis/dermatomyositis (PM/DM), anti-aminoacyl-tRNA synthetase
(ARS) antibodies are closely associated with interstitial lung disease (ILD), a frequent …

[HTML][HTML] Idiopathic pleuroparenchymal fibroelastosis: consideration of a clinicopathological entity in a series of Japanese patients

H Kusagaya, Y Nakamura, M Kono, Y Kaida… - BMC Pulmonary …, 2012 - Springer
Background Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a recently reported
group of disorders characterized by fibrotic thickening of the pleural and subpleural …

Plasma CCN2 (connective tissue growth factor; CTGF) is a potential biomarker in idiopathic pulmonary fibrosis (IPF)

M Kono, Y Nakamura, T Suda, M Kato, Y Kaida… - Clinica Chimica …, 2011 - Elsevier
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal
pulmonary fibrotic disease and useful biomarkers are required to diagnose and predict …

[HTML][HTML] Radiologic pleuroparenchymal fibroelastosis-like lesion in connective tissue disease-related interstitial lung disease

Y Enomoto, Y Nakamura, TV Colby, T Johkoh… - PLoS …, 2017 - journals.plos.org
Background Radiologic pleuroparenchymal fibroelastosis (PPFE)-like lesion including
pulmonary apical cap can be occasionally observed in clinical settings. However, the …

[HTML][HTML] Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease

M Kono, K Miyashita, R Hirama, Y Oshima, K Takeda… - Respiratory …, 2021 - Elsevier
Background Acute exacerbation (AE) of interstitial lung disease (ILD) is an acute respiratory
deterioration of unknown etiology, associated with high mortality. Currently, bronchoalveolar …

[HTML][HTML] Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial …

K Yoshimura, M Kono, Y Enomoto, K Nishimoto… - Respiratory …, 2018 - Elsevier
Background Interstitial lung diseases are heterogeneous, and patients with chronic fibrosing
interstitial pneumonia (CFIP) often have clinical, serologic, and morphologic features …